Cayman Chemical SM-102 amino lipid

Tuesday, 05 September, 2023 | Supplied by: Sapphire Bioscience

SM-102 is an ionisable cationic amino lipid that has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). Administration of luciferase mRNA in SM-102-containing LNPs induces hepatic luciferase expression in mice. Formulations containing SM-102 have been used in the development of LNPs for delivery of mRNA-based vaccines.

Cayman Chemical’s SM-102 is distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...

Content from other channels on our network

From compliance to circularity: three ways pharma manufacturers can rethink resource management

Tomago Aluminium smelter gets green investment

Stantec acquires Sydney-based consultancy

Researchers recover silver from end-of-life solar panels

Soft Low-E coated photovoltaic glass reduces energy demand

SPC Global expands its Aussie-made footprint across North Asia

Food fraud study in the UK estimates costs to economy

Australia and Vietnam trade talks progress

foodpro wrap-up: the event welcomed over 10,000 visitors

interpack China to partner with AIP

$100K fine follows tower crane incident that caused hospital roof collapse

Nexon partners with Dementia Australia to tackle dementia stigma in the workplace

"Migrant worker exploitation" sees NSW aged care provider repay nearly $120K

A Day in the Life of a birth suite ANUM

Professor Andrea Driscoll MACN wins 2026 Nursing Trailblazers Award